Over the past 12 months, 7 insiders at Aura Biosciences, Inc. filed 15 open-market SEC Form 4 transactions on AURA: 0 purchases worth $0 and 15 sales worth $40.1M. Insiders have been net sellers over this period. The most recent filing was on Jun 16, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 26 | Anthony S GibneySee Remarks | SELL | 12.8K | $6.42 | $82K |
| May 7, 26 | Matrix Capital Management Company, Lp | SELL | 6.92M | $5.64 | $39.0M |
| Apr 16, 26 | Conor KilroySee Remarks | SELL | 11.7K | $7.02 | $82K |
| Feb 17, 26 | Amy ElazzouziSenior Vice President, Finance | SELL | 8.5K | $5.06 | $43K |
| Feb 17, 26 | Janet Jill HopkinsChief Medical Officer | SELL | 20.4K | $5.06 | $103K |
| Feb 17, 26 | Conor KilroySee Remarks | SELL | 12.1K | $5.05 | $61K |
| Feb 17, 26 | Mark PlavsicChief Technology Officer | SELL | 15.9K | $5.05 | $80K |
| Feb 17, 26 | De Los Pinos ElisabetSee Remarks | SELL | 47.6K | $5.06 | $241K |
| Jan 20, 26 | Amy ElazzouziSenior Vice President, Finance | SELL | 1.6K | $4.86 | $8K |
| Jan 20, 26 | De Los Pinos ElisabetSee Remarks | SELL | 16.9K | $4.86 | $82K |
| Nov 17, 25 | Janet Jill HopkinsChief Medical Officer | SELL | 17.1K | $5.42 | $93K |
| Oct 29, 25 | Amy ElazzouziSenior Vice President, Finance | SELL | 896 | $6.35 | $6K |
| Oct 29, 25 | De Los Pinos ElisabetSee Remarks | SELL | 9.0K | $6.35 | $57K |
| Oct 16, 25 | Mark PlavsicChief Technology Officer | SELL | 12.2K | $6.35 | $77K |
| Aug 18, 25 | Amy ElazzouziSenior Vice President, Finance | SELL | 7.7K | $6.70 | $52K |
| May 16, 25 | Anthony S GibneySee Remarks | BUY | 50.0K | $4.90 | $245K |
| May 16, 25 | Anthony S GibneySee Remarks | SELL | 1.5K | $5.15 | $8K |
| May 16, 25 | David Michael JohnsonDirector | BUY | 20.0K | $4.90 | $98K |
| Apr 16, 25 | Amy ElazzouziSenior Vice President, Finance | SELL | 897 | $5.49 | $5K |
| Apr 16, 25 | Conor KilroySee Remarks | SELL | 7.2K | $5.49 | $39K |
| Feb 18, 25 | Amy ElazzouziSenior Vice President, Finance | SELL | 1.4K | $7.75 | $11K |
| Feb 18, 25 | Janet Jill HopkinsChief Medical Officer | SELL | 2.5K | $7.75 | $20K |
| Feb 18, 25 | Mark PlavsicChief Technology Officer | SELL | 2.2K | $7.75 | $17K |
| Feb 18, 25 | De Los Pinos ElisabetSee Remarks | SELL | 20.2K | $7.75 | $157K |
| Jan 21, 25 | Amy ElazzouziVice President, Finance | SELL | 1.0K | $7.67 | $8K |
| Jan 21, 25 | De Los Pinos ElisabetSee Remarks | SELL | 16.0K | $7.67 | $122K |
| Nov 18, 24 | Janet Jill HopkinsChief Medical Officer | SELL | 11.8K | $9.36 | $111K |
| Oct 29, 24 | Amy ElazzouziVice President, Finance | SELL | 553 | $10.74 | $6K |
| Oct 29, 24 | De Los Pinos ElisabetSee Remarks | SELL | 9.2K | $10.74 | $99K |
| Oct 18, 24 | Julie B FederChief Financial Officer | SELL | 25.1K | $12.03 | $302K |
| Oct 18, 24 | De Los Pinos ElisabetSee Remarks | SELL | 25.0K | $12.04 | $301K |
| Oct 16, 24 | Mark PlavsicChief Technology Officer | SELL | 7.4K | $9.85 | $73K |
| Jan 23, 24 | Julie B FederChief Financial Officer | SELL | 6.6K | $7.64 | $50K |
| Jan 23, 24 | De Los Pinos ElisabetSee Remarks | SELL | 15.9K | $7.64 | $121K |
| Nov 9, 23 | Matrix Capital Management Company, LpTenPercentOwner | BUY | 1.56M | $9.00 | $14.0M |
| Nov 8, 23 | David Michael JohnsonDirector | BUY | 10.0K | $7.30 | $73K |
| Nov 7, 23 | David Michael JohnsonDirector | BUY | 76.0K | $7.17 | $545K |
| Nov 6, 23 | Julie B FederChief Financial Officer | SELL | 3.9K | $12.07 | $47K |
| Nov 6, 23 | De Los Pinos ElisabetSee Remarks | SELL | 7.4K | $12.03 | $90K |
| Oct 30, 23 | Julie B FederChief Financial Officer | SELL | 3.4K | $6.82 | $23K |
| Oct 30, 23 | De Los Pinos ElisabetSee Remarks | SELL | 9.6K | $6.83 | $65K |
| Oct 4, 23 | David Michael JohnsonDirector | BUY | 6.6K | $8.61 | $57K |
| Oct 3, 23 | David Michael JohnsonDirector | BUY | 13.5K | $8.27 | $112K |
| Jan 6, 23 | David Michael JohnsonDirector | BUY | 904 | $10.51 | $10K |
| Jan 5, 23 | David Michael JohnsonDirector | BUY | 300 | $10.00 | $3K |
| Dec 28, 22 | David Michael JohnsonDirector | BUY | 2.0K | $9.75 | $20K |
| Dec 5, 22 | Matrix Capital Management Company, LpTenPercentOwner | BUY | 1.25M | $12.00 | $15.0M |
| Dec 1, 22 | David Michael JohnsonDirector | BUY | 5.0K | $12.37 | $62K |
| Oct 31, 22 | Rosch Mark DeChief Operating Officer | SELL | 1.1K | $12.46 | $14K |
| Oct 31, 22 | Julie B FederChief Financial Officer | SELL | 2.0K | $12.45 | $25K |
Over the past 12 months, insiders at Aura Biosciences, Inc. filed 0 open-market purchases worth $0 and 15 sales worth $40.1M on AURA, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 16, 26.
The largest recent open-market AURA insider purchase in our data was $15.0M by Matrix Capital Management Company, Lp, TenPercentOwner, filed on Dec 5, 22.
7 different insiders at Aura Biosciences, Inc. filed open-market SEC Form 4 transactions on AURA over the last 12 months.
InsiderTape plots every AURA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Aura Biosciences, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →